170 related articles for article (PubMed ID: 6733024)
1. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
Wheeler KT; Wallen CA; Wolf KL; Siemann DW
Br J Cancer; 1984 Jun; 49(6):787-93. PubMed ID: 6733024
[TBL] [Abstract][Full Text] [Related]
2. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
Wong KH; Wallen CA; Wheeler KT
J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513
[TBL] [Abstract][Full Text] [Related]
3. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
5. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Mulcahy RT; Dembs N
Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
[TBL] [Abstract][Full Text] [Related]
6. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
[TBL] [Abstract][Full Text] [Related]
7. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
Wong KH; Zhang H; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675
[TBL] [Abstract][Full Text] [Related]
8. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
9. Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
Hill SA; Keng PC; Siemann DW
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1615-8. PubMed ID: 6480449
[TBL] [Abstract][Full Text] [Related]
10. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
11. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
[TBL] [Abstract][Full Text] [Related]
12. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
13. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
Mulcahy RT
Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
[TBL] [Abstract][Full Text] [Related]
14. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
Hill SA; Bauer KD; Keng PC; Siemann DW
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
17. In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
Siemann DW; Wolf K; Morrissey S; Wheeler KT
Br J Cancer; 1984 Jun; 49(6):795-9. PubMed ID: 6733025
[No Abstract] [Full Text] [Related]
18. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
Mulcahy RT; Gipp JJ; Tanner MA
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):57-65. PubMed ID: 3496311
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
Hirst DG; Brown JM; Hazlehurst JL
Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
[TBL] [Abstract][Full Text] [Related]
20. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
Lee FY; Workman P
Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]